IL13RA2 and glioblastoma: By describing the molecular subset of GBM over-expressing IL13Rα2 and the intrinsic biology of these tumors, the studies presented here provide a greater understanding of the potential therapeutic utility of IL13Rα2-targeting therapies for this patient population, and provide the foundation for future refinements of these therapies.